Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1998-8-25
pubmed:abstractText
PNU145156E (7,7-(carbonyl-bis[imino-N-methyl-4, 2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino]) -bis-(1, 3-naphthalene disulfonate)) is a naphthalene sulfonic distamycin A derivative that interacts with heparin-binding growth factors. Because PNU145156E inhibits tumor angiogenesis, it was selected for clinical development. Picosecond time-resolved fluorescence emission and anisotropy were used to characterize the binding of PNU145156E to the basic fibroblast growth factor (a protein associated with tumor angiogenesis). A decrease in PNU145156E fluorescence lifetime was observed as a function of human basic fibroblast growth factor (bFGF) concentration. Nonlinear least-squares fitting of the binding isotherm yielded Kd = 145 nM for a single class of binding sites. Time-resolved anisotropy gave Kd = 174 nM. Kd = 150 nM was independently verified by quantitative high-performance affinity chromatography. The displaced volume of the complex, calculated from its rotational correlation time, fitted a sphere of 1:1 stoichiometry. These results account for the formation of a tight yet reversible PNU145156E:bFGF complex. An evaluation of PNU145156E fluorescence lifetimes in various solvents has highlighted the forces involved in stabilizing the complex. These are mostly electrostatic-hydrophobic in nature, with a relatively low contribution from hydrogen bonding. Both polar and nonpolar groups are involved on the protein-binding site within a largely hydrophobic cleft. A potential binding trajectory, based on a combination of these results with site-directed chemical modification and known bFGF x-ray structure, is suggested.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1309590, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1375283, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1381547, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1390688, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1541279, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1655276, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1694687, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1702556, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1703045, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1847668, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-1926336, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-2042958, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-2202382, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-2432664, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-2549857, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-2581424, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-2832850, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-3307323, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-357745, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-4938153, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-7508230, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-7530374, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-7536345, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-7665610, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-7691311, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-7780086, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-7781141, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-7929426, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-8073404, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-8142385, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-8276782, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-8289200, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-8599088, http://linkedlifedata.com/resource/pubmed/commentcorrection/9675169-8789123
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0006-3495
pubmed:author
pubmed:issnType
Print
pubmed:volume
75
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
672-82
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Nature of interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(Carbonyl-bis[imino-N-methyl-4, 2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino] )bis-(1, 3-naphthalene disulfonate).
pubmed:affiliation
Department of Oncology, Preclinical Research, Pharmacia & Upjohn, 20014 Nerviano, Milan, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't